Mostafa M. Kamal
2016
In 2016, Mostafa M. Kamal earned a total compensation of $1.8M as Chief Executive Officer Magellan Rx Management at Magellan Health, a 13% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $492,204 |
|---|---|
| Option Awards | $337,296 |
| Salary | $412,000 |
| Stock Awards | $500,005 |
| Other | $30,300 |
| Total | $1,771,805 |
Kamal received $500K in stock awards, accounting for 28% of the total pay in 2016.
Kamal also received $492.2K in non-equity incentive plan, $337.3K in option awards, $412K in salary and $30.3K in other compensation.
Rankings
In 2016, Mostafa M. Kamal's compensation ranked 5,448th out of 14,075 executives tracked by ExecPay. In other words, Kamal earned more than 61.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,448 out of 14,075 | 61st |
Division Services | 961 out of 2,282 | 58th |
Major group Health Services | 85 out of 209 | 59th |
Industry group Hospitals | 35 out of 51 | 31st |
Source: SEC filing on April 12, 2017.
Kamal's colleagues
We found four more compensation records of executives who worked with Mostafa M. Kamal at Magellan Health in 2016.